OR
ORANY
ORANGE
$20.53
+2.45%
No data for this timeframe.
Vol
Inst. Holders6 funds
Inst. Value$48.4M
Inst. Activity0 buys / 6 sells
SEC Reports1
Recent Activity
Feb 28, 2026
SEC
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — fully exited their positions in
INST-CLUSTER — Impact 7/10
Inst.
CITADEL ADVISORS LLC — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$21.39
Current $20.14
Low $18.10
Median $22.58
High $23.50
3 analysts
$18.10
$23.50
Analyst Ratings
4Strong Buy
9Buy
10Hold
0Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $1.39 ▼ -1.3% | $1.39 — $1.39 | 36% YoY | 1 |
| Next FY | $1.57 ▼ -1.9% | $1.57 — $1.57 | 13% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $38.6M | EXIT |
| WELLS FARGO & COMPANY/MN | $4.9M | EXIT |
| UBS Group AG | $1.8M | EXIT |
| NORGES BANK | $1.3M | EXIT |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $1.2M | EXIT |
6 institutional holders with $48.4M total value (4,215,295 shares) as of 2024-Q3. Top holders: MORGAN, WELLS, UBS. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2024-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 3,365,406 | $38.6M | 79.8% | EXIT -100.0% |
| 2 | WELLS FARGO & COMPANY/MN | 425,159 | $4.9M | 10.1% | EXIT -100.0% |
| 3 | UBS Group AG | 160,072 | $1.8M | 3.8% | EXIT -100.0% |
| 4 | NORGES BANK | 113,600 | $1.3M | 2.7% | EXIT -100.0% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 104,033 | $1.2M | 2.5% | EXIT -100.0% |
| 6 | CITADEL ADVISORS LLC | 47,025 | $539.8K | 1.1% | EXIT -100.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | EXIT | 47,025 | 0 | -100.0% | $0.00 | 2024-Q4 |
| UBS Group AG | EXIT | 160,072 | 0 | -100.0% | $0.00 | 2024-Q4 |
| NORGES BANK | EXIT | 113,600 | 0 | -100.0% | $0.00 | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | EXIT | 425,159 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 104,033 | 0 | -100.0% | $0.00 | 2024-Q4 |
| MORGAN STANLEY | EXIT | 3,365,406 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 104,033 | — | $1.2M | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 57% buy across 23 analysts — 4 strong buy, 9 buy, 10 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$21.39 mean target
$18.10 Low
$23.50 High
| Metric | Value |
|---|---|
| Current Price | $20.14 |
| Target Low | $18.10 |
| Target Mean | $21.39 |
| Target Median | $22.58 |
| Target High | $23.50 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $10.0B | 0.9% | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $10.0B | 0.4% | — |
| Current FY 2026-12-31 |
$1.39 | $1.39 | $1.39 | 36.4% | -1.3% | 0↑ 1↓ | $44.7B | 10.5% | 1 |
| Next FY 2027-12-31 |
$1.57 | $1.57 | $1.57 | 13.3% | -1.9% | 0↑ 1↓ | $49.1B | 9.9% | 1 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 9 | 10 | 0 | 0 | 57% | |
| May 1, 2026 | 3 | 9 | 11 | 0 | 0 | 52% | |
| Apr 1, 2026 | 4 | 9 | 11 | 0 | 0 | 54% | |
| Mar 1, 2026 | 5 | 10 | 9 | 0 | 0 | 63% | |
| Feb 1, 2026 | 6 | 12 | 6 | 0 | 0 | 75% | |
| Jan 1, 2026 | 5 | 12 | 7 | 0 | 0 | 71% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.